Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
After finishing at $3.37 in the prior trading day, BioXcel Therapeutics Inc (NASDAQ: BTAI) closed at $2.97, down -11.87%. In other words, the price has decreased by -$11.87 from its previous closing price. On the day, 1.47 million shares were traded.
Ratios:
Our goal is to gain a better understanding of BTAI by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.81 and its Current Ratio is at 1.87.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, UBS on February 21, 2024, Downgraded its rating to Neutral and sets its target price to $4 from $9 previously.
On August 15, 2023, Mizuho Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $40 to $4.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 16 ’24 when O’Neill Vincent sold 165 shares for $0.35 per share. The transaction valued at 58 led to the insider holds 19,957 shares of the business.
Mehta Vimal sold 3,117 shares of BTAI for $1,131 on Dec 16 ’24. The CEO and President now owns 59,605 shares after completing the transaction at $0.36 per share. On Dec 16 ’24, another insider, Steinhart Richard I, who serves as the Chief Financial Officer of the company, sold 577 shares for $0.36 each. As a result, the insider received 207 and left with 20,932 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 4.29.
Stock Price History:
Over the past 52 weeks, BTAI has reached a high of $52.80, while it has fallen to a 52-week low of $1.72. The 50-Day Moving Average of the stock is -32.43%, while the 200-Day Moving Average is calculated to be -73.48%.
Shares Statistics:
A total of 3.29M shares are outstanding, with a floating share count of 2.74M. Insiders hold about 16.85% of the company’s shares, while institutions hold 16.42% stake in the company.
